The Technical Analyst
Yield10 Bioscience Inc [YTEN]
Exchange: NASDAQ Capital Market Sector: Basic Materials Industry: Agricultural Inputs
Yield10 Bioscience Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: SELL (auto-tracking)
-0.44% $2.24
Last updated: 3 jul 2022 - 20:19
TimeZone: America/New_York
FIND ALL MARKETS
FIND ALL STOCKS LISTED @ NASDAQ Live Signal Oslo
Live Signal Nasdaq
Live Signal Crypto
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 10.98 mill |
| EPS: | -2.42 |
| P/E: | 0.000 |
| Earnings Date: | Aug 09, 2022 |
| SharesOutstanding: | 4.90 mill |
| Avg Daily Volume: | 0.218 mill |
| RATING 2022-07-01 |
|---|
| B+ |
| Neutral |
| RATINGDETAILS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Neutral | |
| P/E: | Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/20 | 1/21 | 2/21 | 3/21 | 4/21 | 1/22 | |
| Revenue | ||||||
| Gr.Profit | n/a | n/a | n/a | n/a | ||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$3.37 (50.28%) $1.126 |
| Date: 2022-07-04 |
| True Range Average |
|---|
|
+/- $0.219 ( +/- 9.78%) Range: 2.02 - 2.46 |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-06-30 | Van Nostrand Robert L | Buy | 2 134 | Stock Option (right to buy) |
| 2022-06-30 | Sinskey Anthony J | Buy | 3 680 | Stock Option (right to buy) |
| 2022-05-25 | Sinskey Anthony J | Buy | 5 000 | Stock Option (right to buy) |
| 2022-05-25 | Van Nostrand Robert L | Buy | 5 000 | Stock Option (right to buy) |
| 2022-05-25 | Brown Sherri M. | Buy | 5 000 | Stock Option (right to buy) |
| INSIDER POWER |
|---|
| 96.99 |
| Last 100 transactions |
| Buy: 1 699 848 | Sell: 85 267 |
Forecast:
16:00 - $2.23
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $2.23
Forecast 2: 16:00 - $2.23
Forecast 3: 16:00 - $2.23
SCORE
-10.00
Sell
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $2.24 (-0.44% ) |
| Volume | 0.0252 mill |
| Avg. Vol. | 0.218 mill |
| % of Avg. Vol | 11.52 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For YTEN
16 Signals | Accuracy: 25.00% | Accuracy Buy: 25.00% | Accuracy Sell: 25.00%
Avg return buy: -1.25 % | Avg return sell: 1.27 %
$1 invested is now $0.90 or -9.72% since 30-06-22
| Date | Signal | @ | Closed | % | Jul 1 - 15:59 | sell | $2.23 | N/A | Active |
|---|---|---|---|---|
| Jul 1 - 15:44 | buy | $2.27 | $2.23 @ Jul 1 - 15:59 | -1.80% |
| Jul 1 - 15:40 | sell | $2.25 | $2.27 @ Jul 1 - 15:44 | 0.93% |
| Jul 1 - 15:12 | buy | $2.26 | $2.25 @ Jul 1 - 15:40 | -0.32% |
| Jul 1 - 12:54 | sell | $2.24 | $2.26 @ Jul 1 - 15:12 | 0.77% |
| Jul 1 - 12:52 | buy | $2.32 | $2.24 @ Jul 1 - 12:54 | -3.45% |
| Jul 1 - 12:53 | sell | $2.24 | $2.32 @ Jul 1 - 12:52 | 3.58% |
| Jul 1 - 11:49 | buy | $2.32 | $2.24 @ Jul 1 - 12:53 | -3.45% |
| Jul 1 - 10:02 | sell | $2.25 | $2.32 @ Jul 1 - 11:49 | 3.12% |
| Jul 1 - 09:44 | buy | $2.30 | $2.25 @ Jul 1 - 10:02 | -2.17% |
YTEN
Yield10 Bioscience, Inc., formerly Metabolix, Inc., is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn. The Company concentrates on technologies that enables it to improve carbon dioxide fixation efficiency in photosynthesis and its direction to and conversion into plant matter. The Company has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.
Latest Press Releases
2022-04-27 09:15:00 - Press Release
Yield10 Bioscience Names Willie Loh, Ph.d., Former Cargill Executive, As Special Commercial And Technical Advisor
Woburn, mass., april 27, 2022 (globe newswire) -- yield10 bioscience, inc. (nasdaq:yten) (“yield10” or the “company”), an agricultural bioscience company, today named willie loh, ph.d., as a special advisor to the board of directors and management of the company, effective immediately. dr. loh previously served as vice president, market development, global edible oils division at cargill incorporated, the global food and agriculture company.
2022-03-08 08:30:00 - Press Release
Yield10 Bioscience Announces Recent Advances In The Development Of Camelina As A Production Platform For Pha Bioplastic
-acre-scale seed production planned in spring 2022
2022-03-03 08:30:00 - Press Release
Yield10 Bioscience Announces An Update On The Camelina Line E3902 Development Program For Producing Low-carbon Feedstock Oil For Renewable Diesel
Company is scaling up camelina line e3902 seed production and developing herbicide tolerant lines
2022-03-01 08:30:00 - Press Release
Yield10 Bioscience Field Test Results Show Seed Oil Content Increase in Camelina And Canola
Increasing oil content in oilseed crops is required to meet the projected demand for renewable diesel increasing oil content in oilseed crops is required to meet the projected demand for renewable diesel
2022-02-02 08:30:00 - Press Release
Yield10 Bioscience Receives Favorable Ruling From The Argentine Biosafety Commission (conabia) For Company's Camelina Lines
Three yield10 crispr genome-edited camelina lines were determined to be similar to conventional camelina varieties and not subject to regulation three yield10 crispr genome-edited camelina lines were determined to be similar to conventional camelina varieties and not subject to regulation
Latest News
2022-06-15 08:30:00 - GlobeNewsWire
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the CROPS 2022: Improving Agriculture Through Genomics Conference
WOBURN, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the CROPS 2022: Improving Agriculture Through Genomics Conference taking place June 13 through June 16, 2022 in Huntsville, Alabama.
2022-06-14 10:04:16 - Zacks Investment Research
5 Stocks to Watch on Robust Agriculture Operations Industry Trends
The Agriculture - Operations industry shows potential on solid demand trends, organic product growth and innovation ability. Players like ADM, CTVA, YTEN, AGRO and CVGW have placed themselves well.
2022-05-19 08:30:00 - GlobeNewsWire
Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference
WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the H.C. Wainwright Global Hybrid Investment Conference. The conference is being held on May 23 – 26, 2022 at the Fontainebleau Hotel in Miami Beach, FL.
2022-05-12 04:19:06 - Seeking Alpha
Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q1 2022 Results - Earnings Call Transcript
Yield10 Bioscience, Inc. (NASDAQ:YTEN ) Q1 2022 Results Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Lynne Brum - Vice President, Planning and Corporate Communications Oliver Peoples - President and Chief Executive Officer Kristi Snell - Vice President, Research and Chief Science Officer Charles Haaser - Vice President, Finance and Chief Accounting Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Anthony Vendetti - Maxim Group Michael Irwin - Univest Securities, LLC Operator Welcome to the First Quarter 2022 Financial Results and Business Update Conference Call for Yield10 Bioscience. During the call, participants will be in a listen-only mode.
2022-05-11 18:49:12 - Zacks Investment Research
Metabolix, Inc. (YTEN) Reports Q1 Loss, Misses Revenue Estimates
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -3.03% and 10.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
2022-05-03 08:30:00 - GlobeNewsWire
Yield10 Bioscience to Announce First Quarter 2022 Financial Results and Host a Conference Call on Wednesday, May 11, 2022
WOBURN, Mass., May 03, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its first quarter 2022 financial results and provide a corporate update on Wednesday, May 11, 2022.
2022-04-08 19:25:06 - InvestorPlace
Should You Buy Wheat Stocks? 3 Companies To Consider.
Surging wheat prices could provide systemic support to many commodity stocks that have U.S. exposure. Here are three wheat stocks to buy.
2022-03-22 08:30:00 - GlobeNewsWire
Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat
WOBURN, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held March 28-30, 2022.
2022-03-16 08:30:00 - GlobeNewsWire
Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference
2022-03-09 22:45:28 - Seeking Alpha
Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q4 2021 Results - Earnings Call Transcript
Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q4 2021 Results - Earnings Call Transcript